IRIS
PAGNESI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.650
EU - Europa 2.566
AS - Asia 1.080
Continente sconosciuto - Info sul continente non disponibili 346
SA - Sud America 108
AF - Africa 33
OC - Oceania 5
Totale 6.788
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.462
RU - Federazione Russa 1.298
IT - Italia 889
CN - Cina 319
SG - Singapore 303
BD - Bangladesh 175
HK - Hong Kong 109
FR - Francia 94
CA - Canada 80
GB - Regno Unito 77
BR - Brasile 70
SE - Svezia 50
VN - Vietnam 42
DE - Germania 41
IN - India 40
JM - Giamaica 28
PL - Polonia 23
MX - Messico 22
NL - Olanda 22
ES - Italia 17
ZA - Sudafrica 17
CR - Costa Rica 16
FI - Finlandia 15
JP - Giappone 15
IQ - Iraq 12
SA - Arabia Saudita 9
TR - Turchia 9
VE - Venezuela 9
AR - Argentina 8
EC - Ecuador 8
HN - Honduras 8
AT - Austria 7
MY - Malesia 7
NI - Nicaragua 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
PH - Filippine 6
TT - Trinidad e Tobago 6
CH - Svizzera 5
PK - Pakistan 5
RO - Romania 5
AU - Australia 4
BB - Barbados 4
PR - Porto Rico 4
SV - El Salvador 4
UA - Ucraina 4
ID - Indonesia 3
IE - Irlanda 3
IL - Israele 3
KW - Kuwait 3
PT - Portogallo 3
PY - Paraguay 3
TH - Thailandia 3
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
EE - Estonia 2
EG - Egitto 2
JO - Giordania 2
KE - Kenya 2
LT - Lituania 2
MA - Marocco 2
SY - Repubblica araba siriana 2
UZ - Uzbekistan 2
AI - Anguilla 1
AL - Albania 1
AO - Angola 1
AW - Aruba 1
BE - Belgio 1
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
CL - Cile 1
CU - Cuba 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
HT - Haiti 1
KR - Corea 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
PE - Perù 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SO - Somalia 1
SR - Suriname 1
TW - Taiwan 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
VU - Vanuatu 1
Totale 6.442
Salva come PNG Salva come JPEG
Città #
Ashburn 362
Moscow 262
Milan 203
San Jose 202
Council Bluffs 201
Singapore 151
Hong Kong 107
New York 102
Phoenix 96
Dallas 83
Rome 77
Santa Clara 75
Los Angeles 72
Beijing 68
Lauterbourg 65
Orem 51
Naples 46
Shanghai 31
Boston 25
Denver 24
Brescia 23
Miano 23
Atlanta 21
Boardman 21
Chennai 20
Warsaw 20
Bologna 18
Brooklyn 18
Montreal 17
Ho Chi Minh City 16
San Francisco 16
Toronto 16
Kingston 15
Tokyo 15
Chicago 14
Hefei 14
London 13
Catania 12
Houston 12
Lappeenranta 12
Manchester 12
Munich 12
San José 12
Turin 12
Florence 11
North Bergen 11
Poplar 11
Bari 10
Buffalo 10
Las Vegas 10
Mexico City 10
Palermo 10
Princeton 10
Cagliari 9
Philadelphia 9
Queens 9
Frankfurt am Main 8
Genoa 8
Hanoi 8
Lawrence 8
Padua 8
São Paulo 8
Venice 8
Washington 8
Amsterdam 7
Caracas 7
Johannesburg 7
Managua 7
Miami 7
Modena 7
Nuremberg 7
Omaha 7
Querétaro 7
Monza 6
Mumbai 6
Newark 6
Pretoria 6
Verona 6
Pasadena 5
Perugia 5
Reggio Emilia 5
Seattle 5
Stockholm 5
Tampa 5
Canary Wharf 4
Canton 4
Da Nang 4
Delhi 4
Detroit 4
Erbil 4
Figino 4
Guayaquil 4
Ittigen 4
Knoxville 4
Louisville 4
Madrid 4
Minneapolis 4
Québec 4
San Pedro Sula 4
San Salvador 4
Totale 3.058
Salva come PNG Salva come JPEG
Nome #
2024 update in heart failure 386
Lactate Values and Mortality in Patients With Cardiogenic Shock: Insights From the Altshock-2 Registry 185
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub 146
Device-related complications after Impella mechanical circulatory support implantation: An IMP-IT observational multicentre registry substudy 140
Impact of Left Ventricular Outflow Tract Calcification on Pacemaker Implantation After Transcatheter Aortic Valve Implantation With Second-Generation Devices 110
A novel scoring system and decisional algorithm to predict functional recovery after heart valve surgery 108
Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19 105
Integrated clinical role of echocardiography in patients with COVID-19 104
Heart and Lung Multimodality Imaging in COVID-19 100
Neutrophil to lymphocyte ratio: a new preoperative predictive index of postoperative atrial fibrillation 96
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 92
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement 88
Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial 87
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 83
Predictors of high residual gradient after transcatheter aortic valve replacement in bicuspid aortic valve stenosis 83
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 80
Organ perfusion pressure predicts outcomes in cardiogenic shock patients 79
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 76
Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 75
Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment 72
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 69
Prevalence, Burden and Echocardiographic Features of Moderate to Severe Tricuspid Regurgitation: Insights from a Tertiary Referral Center (vol 3, pg 123, 2019) 69
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 67
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 67
Epidemiology, pathophysiology, diagnosis and management of atrial functional mitral regurgitation: An expert opinion paper 66
Heart failure: an update from the last years and a look at the near future 64
Moderate Secondary Mitral Regurgitation: Evolving Evidence and Management Strategies 64
The Relevance of Right Ventricular Function and Dimension in Patients Undergoing Transcatheter Tricuspid Edge-to-Edge Repair 62
Acute Heart Failure: Transitioning From Symptom-Based Care to Remission 61
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial 59
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 58
Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF Trial 57
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF 57
Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure: Insights From the RELAX-AHF-2 Trial 56
Safety and Efficacy Intravenous Istaroxime up to 60 hours for Patients with Pre-Cardiogenic Shock 55
Left Main Spontaneous Coronary Artery Dissection: Clinical Features, Management, and Outcomes 53
Malnutrition and outcomes in patients with tricuspid regurgitation undergoing transcatheter tricuspid valve repair 53
Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial 50
Diuretic De-Escalation in Response to HF Therapy: Are We Closer to Reduced Reliance on Diuretics? 49
Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE-TR registry 49
Transcatheter edge-to-edge mitral valve repair for post-myocardial infarction papillary muscle rupture and acute heart failure: A systematic review 48
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 47
Intra-Aortic Balloon Pumping in Acute Decompensated Heart Failure With Hypoperfusion: From Pathophysiology to Clinical Practice 46
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 46
Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions 46
Assessing aortic flow with doppler echocardiography in cardiogenic shock: A crucial diagnostic tool 46
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 46
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure 45
Prognostic role of tricuspid annular plane systolic excursion/pulmonary artery systolic pressure ratio in patients hospitalized for acute heart failure 44
Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis 44
Ventilation strategies in cardiogenic shock: Insights from the AltShock-2 registry 44
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 44
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 43
Impact of SGLT2 inhibitors on endothelial function and echocardiographic parameters in dilated cardiomyopathy 43
Remote pulmonary artery pressure-guided management of patients with heart failure: A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 43
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 42
April 2021 at a glance: focus on systolic function, quality of life and treatment in heart failure 42
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials 41
Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients with Pre Cardiogenic Shock 41
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry 41
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 41
Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial 41
Combined pre- and post-capillary pulmonary hypertension in left heart disease 41
Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysis 41
Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE 41
Functional Mitral Regurgitation and Heart Failure With Preserved Ejection Fraction: Clinical Implications and Management 40
Clinical Impact of Renal Dysfunction in Patients with Severe Tricuspid Regurgitation and Chronic Heart Failure 40
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 39
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: a sub-analysis of the STRONG-HF randomized clinical trial 39
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial 39
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial 39
Characteristics, Prognosis and ESC/ERS Risk Stratification in Obese Patients with Pulmonary Arterial Hypertension (PAH) 39
Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry 39
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC 38
Mapping of current practices of palliative care for patients with heart failure throughout Europe: A scoping review 38
Socio-economic status and the effect of guideline-directed medical therapy in the STRONG-HF study 38
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors 38
NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial 37
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure 37
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 37
Obesity and inflammation in chronic and acute heart failure 37
Towards a phenotype profiling of the patients with heart failure and preserved ejection fraction 36
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 36
Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists 35
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 35
Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure 35
Corticosteroid burst therapy in patients with acute heart failure: Design of the CORTAHF pilot study 34
Telemedicine for the treatment of heart failure: new opportunities after COVID-19 34
Predicting survival in patients with severe heart failure: Risk score validation in the HELP-HF cohort 34
Noncardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: insights from the STRONG-HF trial 34
Sex differences in patients with advanced heart failure: an analysis of the HELP-HF registry 34
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 33
Pre-admission beta-blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock-2 Registry 33
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF 33
Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trial 32
Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF 32
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial 32
Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF study 32
High troponin levels in patients hospitalized for coronavirus disease 2019: a maker or a marker of prognosis? 32
Deep phenotype characterization of hypertensive response to exercise: implications on functional capacity and prognosis across the heart failure spectrum 31
Totale 5.818
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.312
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.312
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202212 0 0 0 7 3 1 0 1 0 0 0 0
2022/202362 19 15 5 0 0 9 0 8 0 0 2 4
2023/202473 0 5 12 10 12 6 2 15 0 0 6 5
2024/2025230 13 11 2 6 10 31 52 31 15 17 16 26
2025/20263.777 85 45 17 113 169 480 382 334 1.385 353 206 208
2026/20272.607 377 561 578 1.091 0 0 0 0 0 0 0 0
Totale 6.788